FRG2B antibody (Cy7)
Quick Overview for FRG2B antibody (Cy7) (ABIN1421234)
Target
Reactivity
Host
Clonality
Conjugate
Application
-
-
Cross-Reactivity
- Human
-
Purification
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human FRG2B
-
Isotype
- IgG
-
-
anti-FSHD Region Gene 2 Family, Member B (FRG2B) (AA 15-43), (N-Term) antibody
FRG2B Reactivity: Human WB Host: Rabbit Polyclonal RB28883 unconjugated
-
-
Application Notes
- IF(IHC-P) 1:50-200
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Expiry Date
- 12 months
-
-
- FRG2B (FSHD Region Gene 2 Family, Member B (FRG2B))
-
Alternative Name
- FRG2B
-
Background
-
Synonyms: FRG2A, FRG2B, FRG2C, FRG2B_HUMAN, FSHD region gene 2 protein family member B, HSA10-FRG2, Protein FRG2-like-1.
Background: Chromosome 3 is made up of about 214 million bases encoding over 1,100 genes. Notably, there is a chemokine receptor gene cluster and a variety of human cancer related loci on chromosome 3. Particular regions of the chromosome 3 short arm are deleted in many types of cancer cells. Key tumor suppressing genes on chromosome 3 encode apoptosis mediator RASSF1, cell migration regulator HYAL1 and angiogenesis suppressor SEMA3B. Marfan Syndrome, porphyria, von Hippel-Lindau syndrome, osteogenesis imperfecta and Charcot-Marie-Tooth Disease are a few of the numerous genetic diseases associated with chromosome 3.
-
Gene ID
- 441581
Target
-
